Drug Type Recombinant coagulation factor |
Synonyms Coagadex, Coagulation factor X, Coagulation factor X (human) + [6] |
Target |
Action stimulants |
Mechanism F10 stimulants(Coagulation factor X stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (20 Oct 2015), |
RegulationOrphan Drug (United States), Orphan Drug (European Union) |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Factor X Deficiency | United States | 20 Oct 2015 |
Not Applicable | - | vqnaycvqjc(sbrilcwuak) = ubauylbmde tvvezwxsaz (prieyzsvmj ) View more | - | 09 Jul 2022 | |||
Not Applicable | - | - | dabvtnpnso(yqliqpokik) = hkxoppdqgv vjfwcthabk (cglltuppcz ) | - | 10 Jun 2019 | ||
Phase 3 | 16 | pthiahtwvd(thdbuurwht) = vymialldkx ujdoucsqcf (hpgcdwtpqh, 21.01) View more | - | 12 Dec 2014 |